WANG Dong, YAN Peizheng, CHEN Haihong, XU Mengzhen, ZHANG Qingxiang, ZHU Qingjun. Research Progress on the Autophagy Regulation and Drug Therapy of Idiopathic Pulmonary Fibrosis[J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(6): 756-761. DOI: 10.13748/j.cnki.issn1007-7693.2021.06.023
    Citation: WANG Dong, YAN Peizheng, CHEN Haihong, XU Mengzhen, ZHANG Qingxiang, ZHU Qingjun. Research Progress on the Autophagy Regulation and Drug Therapy of Idiopathic Pulmonary Fibrosis[J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(6): 756-761. DOI: 10.13748/j.cnki.issn1007-7693.2021.06.023

    Research Progress on the Autophagy Regulation and Drug Therapy of Idiopathic Pulmonary Fibrosis

    • Idiopathic pulmonary fibrosis(IPF) is a kind of age-related pulmonary fibrosis disease with complex etiology. The pathogenesis of IPF is progressive and irreversible, which eventually leads to respiratory failure and death. In recent years, autophagy has been proved to be involved in the development of IPF. This review summarized the clinical research, animal and cell model research related to autophagy and IPF, and the drug treatment research based on the autophagy. It is hoped that this review will be helpful to clarify the pathological mechanism and drug development of IPF.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return